Discovery and molecular characterization of a Bcl-2–regulated cell death pathway in schistosomes

Erinna F. Lee, Oliver B. Clarke, Marco Evangelista, Zhiping Feng, Terence P. Speed, Elissaveta B. Tchoubrieva, Andreas Strasser, Bernd H. Kalinna, Peter M. Colman, W. Douglas FairlieProceedings of the National Academy of Sciences 2011 · DOI

TL;DR

Researchers have identified a conserved Bcl-2-regulated apoptosis pathway in schistosomes, the parasites responsible for schistosomiasis. This discovery is significant because it reveals a potential new drug target, as a schistosome prosurvival protein was shown to bind a known cancer drug, suggesting a novel therapeutic avenue for this neglected tropical disease.

What Problem Does This Paper Address?

Schistosomiasis, a debilitating disease affecting millions worldwide, is primarily treated with a single drug, praziquantel. The growing concern over drug resistance necessitates the identification of new therapeutic targets. Apoptosis, or programmed cell death, is a fundamental cellular process conserved across many organisms, and its regulation by the Bcl-2 protein family is well-established in mammals, particularly in cancer therapy. However, the existence and nature of such a pathway in schistosomes, parasitic flatworms, remained largely uncharacterized. This paper aims to fill this knowledge gap by identifying and functionally characterizing the components of a Bcl-2-regulated apoptotic pathway in schistosomes, and to explore its potential as a drug target.

Methods

The study employed a multi-pronged approach:

  • Genomic Mining: Researchers used BLAST searches against schistosome genome databases (SchistoDB) to identify proteins with homology to human Bcl-2 family members, including those with BH1-BH4 domains, as well as BH3-only proteins, APAF-1, and caspases.
  • Biochemical Analysis: Recombinant schistosome proteins (specifically sjA) were produced and purified. Binding assays, including solution competition assays and co-immunoprecipitation, were used to investigate protein-protein interactions between schistosome Bcl-2 family members.
  • Cell-Based Assays: Functional studies were conducted using mammalian cell lines (HEK293T and MEFs, including Bax/Bak knockout MEFs). These assays involved enforced expression of schistosome proteins to assess their impact on cell viability, colony formation, and cytochrome c release from mitochondria.
  • Structural Biology: X-ray crystallography was used to determine the structure of a schistosome prosurvival protein (sjA) bound to a Bak BH3 domain peptide, providing atomic-level insight into their interaction.
  • Drug Binding Assays: The binding affinity of the BH3 mimetic drug ABT-737 and its analog to schistosome proteins was assessed.

Datasets

  • Schistosome Genome Databases: GenBank and SchistoDB were used for identifying schistosome Bcl-2 related proteins.
  • Mammalian Cell Lines: HEK293T cells and mouse embryonic fibroblasts (MEFs), including wild-type and bax-/-bak-/- MEFs, were used for functional assays.
  • Protein Data Bank (PDB): The atomic coordinates for the sjA:BakBH3 peptide complex were deposited (PDB ID code 3QBR).

Key Insights and Ideas

  • Conservation of Apoptosis Machinery: The study reveals that schistosomes possess a surprisingly complex and conserved Bcl-2-regulated apoptotic pathway, similar in its tripartite structure (BH3-only, prosurvival Bcl-2-like, and Bax/Bak-like proteins) to that found in humans. This challenges the notion that simpler organisms might have rudimentary cell death mechanisms.
  • Potential for Drug Repurposing: The most exciting finding is that a schistosome prosurvival protein (sjA) binds to ABT-737, a well-established BH3 mimetic drug used in cancer therapy. This suggests that existing drugs targeting Bcl-2 pathways could potentially be adapted or modified for treating parasitic infections.
  • Structural Basis for Drug Design: The crystal structure of sjA bound to a BH3 peptide provides a crucial blueprint for designing highly specific BH3 mimetics that could target schistosome prosurvival proteins while minimizing off-target effects on human counterparts.
  • Evolutionary Significance: The complexity of the schistosome pathway, compared to nematodes, suggests that the evolution of Bcl-2 regulated apoptosis might be more intricate than previously thought, with platyhelminthes occupying an interesting evolutionary position.

Key Results

  • Identification of Pathway Components: Researchers identified schistosome homologs for key components of the Bcl-2 apoptotic pathway, including prosurvival (sjA, sjBcl-2/1), proapoptotic (sjB, sjC, sjBcl-2/2), and BH3-only proteins.
  • Functional Characterization:
    • sjC acted as a potent BH3-only killer in mammalian cells, dependent on Bax and Bak.
  • sjB functioned as a Bax/Bak-like protein, inducing cytochrome c release and suppressing colony formation, with its activity dependent on its BH3 domain.
  • sjA demonstrated prosurvival activity by inhibiting sjC-mediated cell death and sjB-mediated colony formation suppression.
  • Drug Binding: Schistosome prosurvival protein sjA bound to ABT-737 with an IC50 of 170 nM, and overexpression of sjA conferred resistance to ABT-737 in mcl-1-/- MEFs.
  • Structural Confirmation: The crystal structure confirmed that sjA adopts a canonical Bcl-2 protein fold and binds BH3 peptides in a hydrophobic groove, analogous to human Bcl-2 proteins.

Limitations and Future Work

  • In Vitro vs. In Vivo: While functional assays were performed in mammalian cells, direct experiments on adult schistosomes in culture yielded variable results, with some evidence of accelerated parasite death at higher drug concentrations. The authors acknowledge that the moderate affinity of ABT-737 for sjA might necessitate higher affinity compounds for effective antiparasitic action.
  • Specificity of BH3 Mimetics: The paper highlights the need for BH3 mimetics that can selectively target parasite prosurvival proteins without significant cross-reactivity with human Bcl-2 counterparts. The unique BH3-binding profile of sjA suggests this is achievable, but further development is required.
  • Broader Applicability: The study suggests that this approach could be extended to other parasitic flatworms and nematodes, provided they rely on a Bcl-2-regulated apoptotic pathway.
  • Further Characterization of Other Proteins: The identification of additional Bcl-2-related proteins in schistosomes (e.g., sj/smBcl-2/1 and sj/smBcl-2/2) warrants further investigation to fully elucidate their roles in the pathway.

Summary updated

Abstract

Schistosomiasis is an infectious disease caused by parasites of the phylum platyhelminthe. Here, we describe the identification and characterization of a Bcl-2-regulated apoptosis pathway in Schistosoma japonicum and S. mansoni. Genomic, biochemical, and cell-based mechanistic studies provide evidence for a tripartite pathway, similar to that in humans including BH3-only proteins that are inhibited by prosurvival Bcl-2-like molecules, and Bax/Bak-like proteins that facilitate mitochondrial outer-membrane permeabilization. Because Bcl-2 proteins have been successfully targeted with "BH3 mimetic" drugs, particularly in the treatment of cancer, we investigated whether schistosome apoptosis pathways could provide targets for future antischistosomal drug discovery efforts. Accordingly, we showed that a schistosome prosurvival protein, sjA, binds ABT-737, a well-characterized BH3 mimetic. A crystal structure of sjA bound to a BH3 peptide provides direct evidence for the feasibility of developing BH3 mimetics to target Bcl-2 prosurvival proteins in schistosomes, suggesting an alternative application for this class of drugs beyond cancer treatment.
BibTeX
@inproceedings{lee2011discovery,
  author = {Erinna F. Lee and Oliver B. Clarke and Marco Evangelista and Zhiping Feng and Terence P. Speed and Elissaveta B. Tchoubrieva and Andreas Strasser and Bernd H. Kalinna and Peter M. Colman and W. Douglas Fairlie},
  title = {{Discovery and molecular characterization of a Bcl-2–regulated cell death pathway in schistosomes}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2011},
  doi = {10.1073/pnas.1100652108},
}
Figure